Arkema introduces Rilsan® Clear G-170 MED, a fully transparent polyamide for use in breathing masks, tubing and other transparent medical components. Rilsan® Clear G-170 MED is more transparent than glass, lighter and more flexible than polycarbonate for applications in which patient comfort is required.
As the largest allowance holder of the companies who produce HCFC-22 refrigerant, Arkema is working with its customers to ensure an orderly and reliable process to gradually phase-out HCFC-22 (R-22) under the U.S. Environmental Protection Agency’s (EPA) phase-out schedule.
Arkema, the world’s number 1 for specialty polyamides, expands its offering with Rilsan® T range, some new biosourced polyamide 10.10 processed from castor oil. Manufactured at its Serquigny facility in France, it benefits from unrivaled raw material integration, boosted by the recent acquisition of Casda and Hipro as well as a new joint venture with Jayant Agro.
Arkema has reinforced its commitment as a major acrylic modifiers supplier to the industries it serves with the additions of Scott Schwartz as General Manager, Americas, and Jason Lyons, Ph.D., as R&D Manager, Acrylic Additives.
A world leader in high performance polymers, Arkema offers a diverse range of fine powders for the manufacture of prototypes and functional technical short runs using the laser sintering technology. From 14 to 18th of April in Jacksonville (Florida - USA), Arkema will showcase its powders offer at the AMUG 2013 (Additive Manufacturing Users Group) conference which promotes the uses and applications of additive manufacturing technologies.
Arkema is committed to provide the highest quality material for the medical market; this is why almost 10 years ago Arkema began to introduce MED grades for some of its Specialty Polyamides products. An extensive range of MED grades is now available for its main product lines (Pebax® SA 01MED, Rilsan®MED, and Rilsamid®MED) that Arkema will sell exclusively in the medical devices market worldwide.
At an Investor Day taking place today in Paris, Arkema presents its 2016 ambition to become a world leader in specialty chemicals and advanced materials. With a selective and profitable growth strategy, the Group targets sales of 8 billion euros and an EBITDA margin of 16% in 2016 while maintaining gearing below 40%. Beyond, the Group intends to maintain its pace of development and aims to achieve sales of 10 billion euros with an EBITDA margin close to 17% in 2020.Confident in its long term prospects, Arkema announces that its dividend per share will already show a significant step-up in 2012 and targets beyond a 30% payout ratio on adjusted net income.
With a renewed focus on specialty chemicals and innovation, Arkema, a global chemical company and France’s leading chemicals producer, now enters into a new phase in its development. Accordingly, the Group is acquiring a new visual identity and a new signature “Innovative Chemistry” which reflects its new positioning in its high added value niches as well as the quality of its innovation.
Arkema has announced a project for the sale of its tin stabilizer business to PMC Group headquartered in Mount Laurel, NJ, a manufacturer of performance chemicals and plastics. With this proposed divestment of organometallic products, including Thermolite® tin stabilizers, Fascat® catalysts, and fine chemicals, Arkema continues to refocus its activities on fast growing core specialty businesses.